Does RITUXIMAB Cause Diffuse large b-cell lymphoma? 1,571 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,571 reports of Diffuse large b-cell lymphoma have been filed in association with RITUXIMAB (Rituxan). This represents 0.9% of all adverse event reports for RITUXIMAB.
1,571
Reports of Diffuse large b-cell lymphoma with RITUXIMAB
0.9%
of all RITUXIMAB reports
495
Deaths
264
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma From RITUXIMAB?
Of the 1,571 reports, 495 (31.5%) resulted in death, 264 (16.8%) required hospitalization, and 95 (6.0%) were considered life-threatening.
Is Diffuse large b-cell lymphoma Listed in the Official Label?
Yes, Diffuse large b-cell lymphoma is listed as a known adverse reaction in the official FDA drug label for RITUXIMAB.
What Other Side Effects Does RITUXIMAB Cause?
Off label use (39,751)
Drug ineffective (32,186)
Rheumatoid arthritis (19,850)
Pain (16,675)
Fatigue (15,602)
Arthralgia (12,529)
Rash (12,102)
Drug intolerance (11,876)
Infusion related reaction (11,871)
Joint swelling (11,170)
What Other Drugs Cause Diffuse large b-cell lymphoma?
CYCLOPHOSPHAMIDE (1,183)
PREDNISONE (1,062)
METHOTREXATE (1,055)
VINCRISTINE (1,043)
DOXORUBICIN (1,002)
LENALIDOMIDE (779)
TACROLIMUS (595)
DEXAMETHASONE (539)
PREDNISOLONE (506)
MYCOPHENOLATE MOFETIL (502)
Which RITUXIMAB Alternatives Have Lower Diffuse large b-cell lymphoma Risk?
RITUXIMAB vs RITUXIMAB-ABBS
RITUXIMAB vs RITUXIMAB-ARRX
RITUXIMAB vs RITUXIMAB-PVVR
RITUXIMAB vs RIVAROXABAN
RITUXIMAB vs RIVASTIGMINE